Importance of the understanding of the 25-hydroxyvitamin D status for the alendronate treatment of postmenopausal osteoporosis.

被引：0
|
作者：
Yamanaka, M
Ishijima, M
Tokita, A
Kitahara, K
Enomoto, F
Sawa, M
Nozawa, M
Kurosawa, H
机构：
[1] Juntendo Univ, Sch Med, Dept Orthopaed, Tokyo 113, Japan
[2] Juntendo Univ, Sch Med, Dept Pediat, Tokyo 113, Japan
[3] Juntendo Tokyo Kuoto Geriatr Med Ctr, Tokyo, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S463 / S463
页数：1
相关论文
共 50 条
  • [1] Iron and 25-hydroxyvitamin D in postmenopausal women with osteoporosis
    Al-Daghri, Nasser M.
    Yakout, Sobhy
    Ghaleb, Afnan
    Hussain, Syed Danish
    Sabico, Shaun
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (03): : 1387 - 1405
  • [2] Multivitamin therapy corrects low serum levels of 25-hydroxyvitamin D in women with postmenopausal osteoporosis.
    Watts, NB
    Jenkins, ME
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S547 - S547
  • [3] Treatment with etidronate or alendronate in postmenopausal osteoporosis.
    Lissens, MA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S277 - S277
  • [4] Assessment of total and 'free' circulatory 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D3 status in men with osteoporosis.
    Al-Oanzi, ZH
    Varanasi, SS
    Tuck, SP
    Francis, RM
    Datta, HK
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S483 - S483
  • [5] Assessment of total and 'free' circulatory 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D3 status in men with osteoporosis.
    Al-Oanzi, ZH
    Varanasi, SS
    Tuck, SP
    Francis, RM
    Datta, HK
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S483 - S483
  • [6] Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis
    Lee, D. Y.
    Jee, J. H.
    Cho, Y. Y.
    Jang, J. Y.
    Yu, T. Y.
    Kim, T. H.
    Hong, Y. J.
    Hong, W. -J.
    Jin, S. -M.
    Hur, K. Y.
    Kim, J. H.
    Kim, S. W.
    Chung, J. H.
    Lee, M. K.
    Min, Y. -K.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (04) : 1377 - 1384
  • [7] Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis
    D. Y. Lee
    J. H. Jee
    Y. Y. Cho
    J. Y. Jang
    T. Y. Yu
    T. H. Kim
    Y. J. Hong
    W.-J. Hong
    S.-M. Jin
    K. Y. Hur
    J. H. Kim
    S. W. Kim
    J. H. Chung
    M. K. Lee
    Y.-K. Min
    [J]. Osteoporosis International, 2017, 28 : 1377 - 1384
  • [8] The Relationship Between Serum 25-Hydroxyvitamin D Levels and Osteoporosis in Postmenopausal Women
    Wang, Dongmei
    Yang, Yimei
    [J]. CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 619 - 627
  • [9] 25-hydroxyvitamin D status and its impact on cognitive functions in postmenopausal woman
    Raszewski, Grzegorz
    Bojar, Iwona
    Lukawski, Krzysztof
    Bakalczuk, Grzegorz
    Owoc, Alfred
    Wdowiak, Artur
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 588 - 597
  • [10] Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis
    H. C. Hoeck
    B. Li
    P. Qvist
    [J]. Osteoporosis International, 2009, 20
12345